AI Analysis

How does AAREYDRUGS.NS make money? Does AAREYDRUGS.NS have pricing power? What's the Earnings Whisper? Will AAREYDRUGS.NS profit more as the business scales? What is AAREYDRUGS.NS's management track record? Is AAREYDRUGS.NS's current price justified?

Aarey Drugs & Pharmaceuticals Limited

₹113 +$45.45 (+67.28%)

NSE · 16 Oct 2026 09:59 UTC

Previous Close

₹108.74

Day Range

₹105.21₹113.5

Year Range

₹50.31₹113.5

Market Cap

3.2B

AVG Volume

144.31K

Trailing/Forward PE

76.87/-

PEG ratio

-113.77

Dividend Yield

Next Earnings Date

Primary Exchange

National Stock Exchange of India

Revenue (INR) · Q

AAREYDRUGS.NS Revenue (INR) by quarter
Period	Revenue (INR)
27 Q1	446.25M
26 Q4	1.89B
26 Q3	964.26M
26 Q2	841.62M
26 Q1	1.02B
25 Q4	1.08B
25 Q3	1.34B
25 Q2	1.05B
25 Q1	1.27B
24 Q4	2.1B

Net Income (INR) · Q

AAREYDRUGS.NS Net Income (INR) by quarter
Period	Net Income (INR)
27 Q1	10.24M
26 Q4	15.57M
26 Q3	5.7M
26 Q2	10.24M
26 Q1	13.71M
25 Q4	4.7M
25 Q3	7.18M
25 Q2	15.96M
25 Q1	12.39M
24 Q4	21.52M

Operating Income (INR) · Q

AAREYDRUGS.NS Operating Income (INR) by quarter
Period	Operating Income (INR)
27 Q1	4.75M
26 Q4	34.94M
26 Q3	-23.39M
26 Q2	19.5M
26 Q1	12.17M
25 Q4	-34.33M
25 Q3	16.2M
25 Q2	32.34M
25 Q1	25.84M
24 Q4	-18.38M

EBITDA · Q

Cash Flows · Q

EPS · Q

Expenses · Q

Cash & Debt · Q

Debt ratios · Q

Margins · Q

Return on Capital · Q

Shares Outstanding · Q

Dividends (INR) · Q

Employee Count

Book Value Per Share · Q

Total Assets · Q

PE Ratio

Free Cash Flow Yield

Price to Sales

EV/EBITDA

Price/Operating Cashflow

Price to Book

No video analysis for this stock yet. Request one from our team.

AI Analysis

Aarey Drugs & Pharmaceuticals Limited

Video analysis: AAREYDRUGS.NS

News: AAREYDRUGS.NS

Similar companies